News Daily News Ticagrelor Doesn’t Beat Aspirin for Secondary Prevention After Stroke-TIA: SOCRATES Todd Neale May 11, 2016
News Conference News SCAI 2016 Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women L.A. McKeown May 11, 2016
News Daily News Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib Todd Neale April 21, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Daily News Subclinical Atherosclerosis, Dementia Entwined in People in Their 80s and Beyond Todd Neale February 29, 2016
News Daily News In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients Todd Neale January 25, 2016
News Industry News Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis December 07, 2015
News Daily News COURAGE at 15 Years: Still No Survival Advantage for PCI L.A. McKeown November 10, 2015
News Conference News AHA 2015 SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients Todd Neale November 08, 2015
News Daily News ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction Caitlin E. Cox October 28, 2015
News Industry News Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure October 27, 2015
News Industry News Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention October 13, 2015
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015
News Conference News ESC 2015 Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes Yael L. Maxwell September 01, 2015
News Conference News ESC 2015 TECOS: No Differences in Heart Failure Outcomes When Sitagliptin Added to Usual Care in Diabetics Yael L. Maxwell August 31, 2015
News Conference News ESC 2015 Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients L.A. McKeown August 31, 2015